The pharmaceutical industry is undergoing the most profound structural changes in its history. Worldwide drug patents are continually expiring, and over the next few years this figure will amount to hundreds of billions. For pharmaceutical companies this implies considerable partial revenue losses, which must be compensated by new drugs or generics in alternative application areas.
Drug manufacturers must re-align their corporate strategy in order to maintain their market position and be able to expand, even within the changing environment. Both corporate and external market data is required to generate the information needed for quick, uncomplicated evaluation. Intelligent software solutions allow this distributed data to be exchanged, also on a large scale and for it to be used as the basis for corporate strategy decisions.
Click here to read a user report.
To enable brand and generic manufacturers to perform the tactical placement of their products methodically and effectively, COSMO CONSULT offers solutions for analysing sales, market research and data etc. QlikView provides you with evaluation of internal key figures and external data in one solution. It is intuitive, can be applied to any business level and delivers quick results in seconds so that customised decisions about changes can be made and applied directly.
Contract manufacturers are currently being offered opportunities to optimise processes in the storage, delivery and production areas. COSMO CONSULT offers you expert support with the analysis and evaluation of all the data maintained in your systems. Improving the flow of goods and reducing the cost of production in accordance with the applicable regulations are just two of the many possibilities this opens up.
Strategic product placement in the pharmaceutical market requires highly efficient sales management and modern marketing techniques. The associative approach from QlikView offers various options for reaching timely decisions based on an integrated and valid data base. Our users benefit from the following:
The production of a new drug requires years of research and development. Many factors play a role in this. How quickly can the initial research results be obtained? What hurdles could influence the market launch? Use predictive forecasting models to ensure the long-term competitive advantage of your investments:
Supply and distribution channels can vary considerably by region, product type, local regulatory approvals, business relationships, different national conditions and other factors. The variances have a direct impact on costs and your competitiveness. With QlikView, you can control:
If they want to reduce their production costs, pharmaceutical manufacturers must continue to ensure the impeccable quality of their products. An evaluation of the quality management system in order to comply with the GMP guidelines opens up further process optimisation options:
More and more new laws and regulations have led to the emergence of heterogeneous system landscapes, particularly in pharmaceutical companies. Implementing a uniform regulation architecture will generate numerous benefits for your company:
Always having the current figures in view is fundamentally important for meeting the challenge of competition. With our QlikView solution, pharmaceutical companies can access an up to date overview of their figures by clicking on a mouse: